Skip to content

Alcohol Sensitivity Among Older Adults Who Consume Alcohol

Individual Differences in Alcohol Sensitivity

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07636447
Enrollment
80
Registered
2026-06-09
Start date
2026-07-01
Completion date
2028-06-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult Participants

Keywords

Older adults, alcohol drinkers, cognition

Brief summary

This is a proof-of-concept study exploring individual differences in sensitivity to alcohol among older healthy current drinkers aged 65 to 80. Participants will complete two sessions during which they will complete questionnaires and laboratory measures of mental abilities and brain activity and receive a beverage that may or may not contain a moderate dose of alcohol.

Detailed description

As a preliminary, proof-of-concept study, the project is designed to provide information regarding variability in response to a moderate dose of alcohol among healthy men and women who are current drinkers and aged 65 to 80. It is expected that approximately 75 individuals will complete the study. Participants complete two laboratory sessions. Each session will include consuming a beverage that may or may not include alcohol. If the beverage does include alcohol, the volume will not exceed the amount that a drinker might consume in 1 to 2 drinks. The outcomes will provide information regarding the how older adults vary in their response to alcohol and explore whether alcohol sensitivity is related to selected measures of cognition.

Interventions

Described elsewhere

OTHERPlacebo Control

on each of two visits, participants receive either the placebo drink or the drinking containing alcohol

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Alcohol Drinkers who consume alcohol on a regular basis * No history of significant substance misuse * at least 12 years of education or GED equivalence

Exclusion criteria

* current Cigarette smoker * Type 1 Diabetes or uncontrolled Type 2 Diabetes * Epilepsy * Neurodegenerative disorder * Significant psychiatric disorder such as a psychotic disorder, bipolar disorder, current major depression or PTSD

Design outcomes

Primary

MeasureTime frameDescription
Alcohol Effects on Psychomotor Skills as reflected in the Trail Making Test (TMT)The placebo and alcohol sessions occur ~ 10-14 days apart.Difference between the number of seconds required to complete the TMT under placebo vs the alcohol condition for each individual
Alcohol Effects on a Working Memory Task requiring Continuous RecognitionThe placebo and alcohol sessions occur ~ 10-14 days apart.Differences in accuracy in identifying previously seen vs. new items a working memory task under alcohol vs placebo conditions for each individual
Alcohol Effects on Neural Activity Measured from Scalp ElectroencephalographyThe alcohol and placebo sessions occur ~ 10-14 days apart.Differences in neural activity as reflected obtained through non-invasive electroencephalography under alcohol vs placebo conditions for each individual

Secondary

MeasureTime frameDescription
Correlation between alcohol sensitivity and standard cognitive assessmentThe general measure of cognitive abilities is obtained in the first session, prior to the experimental condition. The difference scores are derived by comparing outcomes between alcohol vs placebo sessions which are ~ 10-14 days apart.Correlations between differences under alcohol vs placebo conditions for the psychomotor task, the working memory task, the measure of neural activity and performance on a general measure of cognitive abilities

Countries

United States

Contacts

CONTACTSara Jo Nixon, PhD
sjnixon@ufl.edu352-294-4920
CONTACTBen Lewis, PhD
benlewis@ufl.edu352-294-4920
PRINCIPAL_INVESTIGATORSara Jo Nixon, PhD

University of Florida

PRINCIPAL_INVESTIGATORBen Lewis, PhD

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026